← Back to Search
Characterization Of Crystalline Drug Nanoparticles Using Atomic Force Microscopy And Complementary Techniques
H. Shi, L. Farber, J. Michaels, Allison N. Dickey, Karen C. Thompson, S. Shelukar, P. Hurter, S. Reynolds, M. Kaufman
Published 2004 · Medicine, Chemistry
Download PDFAnalyze on Scholarcy
AbstractPurpose. The purpose of this work was to image crystalline drug nanoparticles from a liquid dispersion and in a solid dosage form for the determination of size, shape, and distribution. Methods. Crystalline drug nanoparticles were adsorbed from a colloidal dispersion on glass for atomic force microscopy (AFM) imaging. Nanoparticles that were spray coated onto a host bead were exposed by ultramicrotomy for scanning electron microscopy and AFM examination. Results. The adsorbed drug nanoparticles were measured by AFM to have a mean diameter of 95 nm and an average aspect ratio of 1.3. Nanoparticles observed in the solid dosage form had a size and shape similar to drug nanoparticles in the dispersion. Particle size distribution from AFM measurement agreed well with data from field emission scanning electron microscopy, static light scattering, and X-ray powder diffraction. Conclusions. AFM is demonstrated to be a valuable tool in visualization and quantification of drug nanoparticle crystals in formulations. In addition to accurate size measurement, AFM readily provides shape and structural information of nanoparticles, which cannot be obtained by light scattering. Ultramicrotomy is a good sample preparation method to expose the interior of solid dosage forms with minimal structural alteration for microscopic examination.
This paper references
SEM and AFM: Complementary Techniques for Surface Investigations
P. Russell (2001)
Atomic force microscope.
An In Situ Dissolution Study of Aspirin Crystal Planes (100) and (001) by Atomic Force Microscopy
A. Danesh (2004)
Intersex Management: What Is Achieved and What Is Needed
R. Rappaport (2006)
Biological atomic force microscopy: what is achieved and what is needed
Z. Shao (1996)
Measurement of interaction forces between individual powder particles using an atomic force microscope
U. Sindel (2001)
scanning electron microscopy and scanning probe microscopy
R. Nessler. Scanning probe technologies (1999)
Atomic Force Microscopy Studies of Solid Lipid Nanoparticles
A. Mühlen (2004)
Scanning tunneling microscopy
G. Binnig (1982)
A mathematical morphology approach to image formation and image restoration in scanning tunnelling and atomic force microscopies
N. Bonnet (1994)
complementary techniques for surface investigations
P. Russel (2001)
Polymorphic Discrimination Using Atomic Force Microscopy: Distinguishing between Two Polymorphs of the Drug Cimetidine
A. Danesh (2000)
Direct adhesion measurements of pharmaceutical particles to gelatin capsule surfaces
Taleb H. Ibrahim (2000)
Principles of Protein
J. Séquaris (1980)
Characterisation of adhesional properties of lactose carriers using atomic force microscopy.
M. Louey (2001)
Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs
G. Liversidge (1995)
Morphological restoration of atomic force microscopy images
D. Wilson (1995)
Fractal Analysis of Pharmaceutical Particles by Atomic Force Microscopy
Tonglei Li (2004)
The Discrimination of Drug Polymorphic Forms from Single Crystals Using Atomic Force Microscopy
A. Danesh (2004)
Elements of X-ray diffraction
B. Cullity (1956)
L. C. Sawyer (1987)
Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats
G. Liversidge (1995)
Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.
R. Mueller (2001)
Morphological estimation of tip geometry for scanned probe microscopy
J. S. Villarrubia (1994)
This paper is referenced by
Nanoparticles: a boon for modernisation of drug delivery: a review
Mohammed Shuaib Khan (2011)
Formulation development of drug nanocrystals and nanoparticles for dermal delivery
P. Maincent (2018)
Production of nabumetone nanoparticles: Effect of molecular weight, concentration and nature of cellulose ether stabiliser.
Daniel J. Goodwin (2016)
Investigation of Enhancement of Furosemide Solubilization with Cyclodextrins and a Novel Octenyl Succinate Anhydride Starch
Rui Bo Zhu (2012)
A study of the formation of magnetically active solid dispersions of phenacetin using atomic and magnetic force microscopy
Liana Stanislavovna Usmanova (2017)
Chapter 2 Nanoparticles Types , Classifi cation , Characterization , Fabrication Methods and Drug Delivery Applications
Nanoparticles Types, Classification, Characterization, Fabrication Methods and Drug Delivery Applications
Saurabh Bhatia (2016)
Hyaluronic acid embedded cellulose acetate phthlate core/shell nanoparticulate carrier of 5-fluorouracil.
A. Garg (2016)
Nanosuspensions: Emerging Novel Agrochemical Formulations
Y. Sasson (2007)
Scanning probe microscopy in the field of drug delivery.
Y. T. A. Turner (2007)
An Insight into Characterizations and Applications of Nanoparticulate Targeted Drug Delivery Systems
Ayan Kumar Barui (2019)
Effect of Polymer-Based Nanoparticles on the Assay of Antimicrobial Drug Delivery Systems
Mehmet Gumustas (2017)
Physicochemical properties of the amorphous drug, cast films, and spray dried powders to predict formulation probability of success for solid dispersions: etravirine.
I. Weuts (2011)
Green nanobiotechnology: factors affecting synthesis and characterization techniques
J. Patra (2014)
A study of sulfamerazine single crystals using atomic force microscopy, transmission light microscopy, and Raman spectroscopy.
X. Cao (2005)
Morphology and microstructural analysis of bioactive-loaded micro/nanocarriers via microscopy techniques; CLSM/SEM/TEM/AFM.
Seid Reza Falsafi (2020)
Physical Characterization of Nanoparticles
R. Haskell (2006)
Solid Nanosuspensions: The Emerging Technology and Pharmaceutical Applications as Nanomedicine
S. Verma (2010)
Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin.
S. Mao (2006)
Nanosuspension Technology: Recent Patents on Drug Delivery and their Characterizations
Surya Goel (2019)
Nanoparticle: An overview of preparation and characterization
S. Pal (2011)
Comparison of powder produced by evaporative precipitation into aqueous solution (EPAS) and spray freezing into liquid (SFL) technologies using novel Z-contrast STEM and complimentary techniques.
J. M. Vaughn (2005)
NANOPARTICLE: AN OVERVIEW OF PREPARATION, CHARACTERIZATION AND APPLICATION
K. Ranjit (2016)
On the physical transformations of processed pharmaceutical solids.
R. Price (2005)
A BRIEF REVIEW ON INORGANIC NANOPARTICLES
P. Pandey (2016)
Crystal structure and surface properties of an investigational drug--a case study.
Y. Kiang (2004)
Polymeric Nanoparticles as Promising Novel Carriers for Drug Delivery : An Overview
Meenakshi Dadwal (2014)
In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery
A. Jain (2019)
Heparin-appended polycaprolactone core/corona nanoparticles for site specific delivery of 5-fluorouracil
A. Garg (2017)
SYNTHESIS AND CHARACTERIZATION OF POLYSIALIC ACID-N-TRIMETHYL CHITOSAN NANOPARTICLES FOR DRUG DELIVERY
Nan Zhang (2012)
Nanocrystalline Cellulose: Production and Applications
S. S. Dalli (2018)
Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles.
Anchalee Jintapattanakit (2007)See more